Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
LETTERS TO THE EDITOR

“Dodgy 6As”: Differentiating Pneumococcal Serotype 6C from 6A by Use of the Quellung Reaction

Kim M. Hare, Heidi Smith-Vaughan, Michael Binks, In Ho Park, Moon H. Nahm, Amanda J. Leach
Kim M. Hare
Menzies School of Health Research Institute of Advanced Studies Charles Darwin University Darwin, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Kim.Hare@menzies.edu.au
Heidi Smith-Vaughan
Menzies School of Health Research Institute of Advanced Studies Charles Darwin University Darwin, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Binks
Menzies School of Health Research Institute of Advanced Studies Charles Darwin University Darwin, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
In Ho Park
Departments of Pathology and Microbiology University of Alabama at Birmingham Birmingham, Alabama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moon H. Nahm
Departments of Pathology and Microbiology University of Alabama at Birmingham Birmingham, Alabama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda J. Leach
Menzies School of Health Research Institute of Advanced Studies Charles Darwin University Darwin, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.00046-09
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

The Quellung reaction has long been the standard method for pneumococcal serotyping (7); however, the new serotype 6C is reportedly indistinguishable from serotype 6A using this method (8). We report an anomalous Quellung reaction associated with serotype 6C, which may aid in diagnostic interpretation.

The 7-valent pneumococcal conjugate vaccine was introduced in Australia for indigenous and other high-risk infants in 2001. In 2002, a serotyping anomaly was noted in a subset of carriage isolates. These isolates appeared negative for all nine pool antisera A to I (covering 90 pneumococcal serotypes) but reacted positively with Omni serum. Following advice from the Pneumococcal Reference Laboratory in Queensland, Australia, we found that these isolates reacted strongly with group 6 antiserum but that factor reactions were weak. Group 6 is included in the B pool. A selection of isolates was sent to Queensland and serotyped as 6A. In 2003, the Statens Serum Institute (SSI) confirmed 10 such isolates as 6A; pool B reactions were mostly weak (+), while pool Q reactions were strongly positive (+++). (Pool Q, which includes group 6, is part of an alternative set of antisera used to identify types present in the 23-valent pneumococcal polysaccharide vaccine.) To distinguish “normal” 6As with strong pool B reactions, we referred to isolates with weak or apparent negative pool B reactions as “dodgy” 6As.

In 2007, when the new serotype 6C was announced (8), we queried whether our dodgy 6As were actually 6Cs. Using a wciN PCR (9), we revealed that 1 of 20 prevaccine isolates recorded as 6A was 6C, while 17 of 18 postvaccine isolates recorded as 6A were 6C, suggesting serotype replacement. All 17 postvaccine serotype 6C isolates had been recorded as dodgy 6As, while the one postvaccine serotype 6A isolate was recorded as a normal 6A. Atypical reactions had not been recorded prevaccine.

To confirm our results, fresh serum broths were prepared and serotyped blinded. All 20 isolates typed as 6A by PCR were normal 6As by the Quellung reaction, while all 18 isolates typed as 6C by PCR were dodgy 6As by the Quellung reaction. Subsequently, another 144 6A isolates from a 2003 to 2005 surveillance study were tested using wciN PCR. All 61 normal 6As were confirmed as 6A, while all 83 dodgy 6As were 6Cs. We have therefore matched PCR results to pool B reactions for 182 isolates previously recorded as 6A (81 [100%] normal 6A isolates were confirmed as serotype 6A by PCR and 101 [100%] dodgy 6A isolates were determined to be 6C by PCR).

We have used five different batches of pool B antiserum since 2002; thus, batch variation is unlikely to have influenced our findings. Furthermore, in a competitive inhibition enzyme-linked immunosorbent assay, 6C polysaccharide antigen did not significantly attenuate the binding of pool B to 6A and 6B polysaccharide antigens. This suggests that pool B may react weakly with serotype 6C. Interestingly, 6C antigen considerably inhibited the binding of pool Q to these antigens, suggesting a strong pool Q reaction with 6C (as reported by SSI).

The Quellung reaction is produced using the Neufeld test, described by Lund (6) and Austrian (1), and the SSI pneumococcal antisera insert (August 2001 revision). Briefly, a drop of specimen is mixed with a drop of typing serum, a coverslip is placed over the mixture, and the preparation is examined using a ×100 magnification oil immersion lens. A positive reaction occurs when type-specific antibody binds to the pneumococcal capsule, causing a change in its refractive index so that it appears “swollen” and more visible. A World Health Organization working group acknowledged the Quellung reaction as the standard method for serotyping pneumococcal isolates but did not detail a recommended method (7).

Recently, 11 reference laboratories in Europe participated in the validation of pneumococcal serotyping (5). A high degree of consensus was found between the Neufeld test and other serotyping methods (agglutination or gel diffusion). Six laboratories used the Neufeld test; however, the magnification used was not specified, nor was the use of oil immersion (5). Australian laboratories routinely use ×40 magnification (4), which is quicker and simpler than ×100. This protocol is accurate and reliable and has been used by experts for more than 30 years (2). According to Henrichsen (3), the Quellung reaction continues to be carried out essentially as described by Austrian, and we find no reference to any modified Neufeld method used outside Australia.

To our eyes, the differing strengths of the pool B reaction with 6A and 6C were clearly visible at both magnifications (Fig. 1). Furthermore, this phenomenon is not confined to pool B antiserum. We have observed that a strong positive pool G reaction indicates serotype 29 or 35B, while a weak positive pool G reaction invariably indicates serotype 34.

We have demonstrated that pneumococcal serotype 6C is associated with a weak pool B reaction which differentiates it from 6A. This information should prove useful for laboratories that use the Quellung reaction, particularly those without the capability for molecular typing.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Quellung reaction photographed using a ×100 magnification oil-immersion lens, giving an appearance similar to that seen at ×40 magnification. (a) 6A pool B reaction (normal); (b) 6C pool B reaction (dodgy); (c) 6C negative control (no antiserum added).

ACKNOWLEDGMENTS

We thank Denise Murphy (Pneumococcal Reference Laboratory, Queensland Health Scientific Services, Australia) and Mette Barendorff Kerrn (Statens Serum Institute, Denmark) for serotyping advice and Peter Christensen (Menzies School of Health Research, Australia) for laboratory assistance.

This study was supported by an NHMRC project grant and NIH grant AI-31473 (M.H.N.).

M.H.N. and I.H.P. are employed by the University of Alabama at Birmingham, which has applied for a patent covering the discovery of serotype 6C.

  • Copyright © 2009 American Society for Microbiology

REFERENCES

  1. 1.↵
    Austrian, R. 1976. The Quellung reaction, a neglected microbiologic technique. Mt. Sinai J. Med.43:699-709.
    OpenUrlPubMedWeb of Science
  2. 2.↵
    Hansman, D. 1983. Serotypes in pneumococcal disease. A ten year study in Australia 1970 through 1979. Aust. N. Z. J. Med.13:359-364.
    OpenUrlPubMedWeb of Science
  3. 3.↵
    Henrichsen, J. 1999. Typing of Streptococcus pneumoniae: past, present and future. Am. J. Med.107:50S-54S.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Kong, F., and G. L. Gilbert. 2003. Using cpsA-cpsB sequence polymorphisms and serotype-/group-specific PCR to predict 51 Streptococcus pneumoniae capsular serotypes. J. Med. Microbiol.52:1047-1058.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Konradsen, H. B. 2005. Validation of serotyping of Streptococcus pneumoniae in Europe. Vaccine23:1368-1373.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Lund, E. 1960. Laboratory diagnosis of Pneumococcus infections. Bull. W. H. O.23:5-13.
    OpenUrlPubMed
  7. 7.↵
    O'Brien, K. L., H. Nohynek, and the W. H. O. Pneumococcal Vaccine Trials Carriage Working Group. 2003. Report from a W. H. O. working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr. Infect. Dis. J.22:e1-e11.
    OpenUrlPubMed
  8. 8.↵
    Park, I. H., D. G. Pritchard, R. Cartee, A. Brandao, M. C. Brandileone, and M. H. Nahm. 2007. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J. Clin. Microbiol.45:1225-1233.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Park, I. H., S. Park, S. K. Hollingshead, and M. H. Nahm. 2007. Genetic basis for the new pneumococcal serotype, 6C. Infect. Immun.75:4482-4489.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
“Dodgy 6As”: Differentiating Pneumococcal Serotype 6C from 6A by Use of the Quellung Reaction
Kim M. Hare, Heidi Smith-Vaughan, Michael Binks, In Ho Park, Moon H. Nahm, Amanda J. Leach
Journal of Clinical Microbiology May 2009, 47 (6) 1981-1982; DOI: 10.1128/JCM.00046-09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
“Dodgy 6As”: Differentiating Pneumococcal Serotype 6C from 6A by Use of the Quellung Reaction
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
“Dodgy 6As”: Differentiating Pneumococcal Serotype 6C from 6A by Use of the Quellung Reaction
Kim M. Hare, Heidi Smith-Vaughan, Michael Binks, In Ho Park, Moon H. Nahm, Amanda J. Leach
Journal of Clinical Microbiology May 2009, 47 (6) 1981-1982; DOI: 10.1128/JCM.00046-09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Pneumococcal Infections
Polysaccharides, Bacterial
Streptococcus pneumoniae

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X